These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21560034)

  • 21. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A
    N Engl J Med; 2014 Oct; 371(17):1609-18. PubMed ID: 25337750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
    Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
    Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
    Moreau LC; Rajan R; Thirlwell MP; Alcindor T
    Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
    Romera A; Peredpaya S; Shparyk Y; Bondarenko I; Mendonça Bariani G; Abdalla KC; Roca E; Franke F; Melo Cruz F; Ramesh A; Ostwal V; Shah P; Rahuman SA; Paravisini A; Huerga C; Del Campo García A; Millán S
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):845-855. PubMed ID: 30262136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
    Tomita M; Kuboi K; Kameyama N; Mitsuhashi H; Matsumoto N; Hasegawa Y; Sekimoto Y
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):121-4. PubMed ID: 21368472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
    Bennouna J; Borg C; Delord JP; Husseini F; Trillet-Lenoir V; Faroux R; François E; Ychou M; Goldwasser F; Bouché O; Senellart H; Kraemer S; Douillard JY
    Clin Colorectal Cancer; 2012 Mar; 11(1):38-44. PubMed ID: 21803002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study.
    Kwon HC; Oh SY; Lee S; Kim SH; Kim HJ
    World J Gastroenterol; 2007 Dec; 13(46):6231-5. PubMed ID: 18069765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of locally advanced rectal cancer responding to FOLFOX].
    Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of poorly differentiated adenocarcinoma of the rectum with disseminated carcinomatosis of the bone marrow successfully treated with mFOLFOX-6/bevacizumab].
    Nonaka K; Sha S; Ito M; Nonaka K; Yamanaka N
    Nihon Shokakibyo Gakkai Zasshi; 2010 Jul; 107(7):1151-8. PubMed ID: 20616483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
    Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
    Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study.
    Bir A; Tan W; Wilding GE; Lombardo J; Fakih MG
    Oncology; 2007; 72(1-2):4-9. PubMed ID: 17971679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Successful chemotherapy of carcinomatosis of the bone marrow with disseminated intravascular coagulation from a rectal carcinoma found by eosinophilia].
    Higashiyama A; Kudo M; Nagasako T; Kawamura N; Abiko S; Yamamoto Y; Takano M; Gotoh J; Tamaki T; Meguro J; Yonekawa M; Kawamura A; Tanino M
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1244-51. PubMed ID: 21737977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
    Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies.
    Iwasa S; Nagashima K; Yamaguchi T; Matsumoto H; Ichikawa Y; Goto A; Yasui H; Kato K; Okita NT; Shimada Y; Yamada Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):605-14. PubMed ID: 26220845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
    Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
    Heinemann V; von Weikersthal LF; Decker T; Kiani A; Vehling-Kaiser U; Al-Batran SE; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Stauch M; Scheithauer W; Hielscher J; Scholz M; Müller S; Link H; Niederle N; Rost A; Höffkes HG; Moehler M; Lindig RU; Modest DP; Rossius L; Kirchner T; Jung A; Stintzing S
    Lancet Oncol; 2014 Sep; 15(10):1065-75. PubMed ID: 25088940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case with liver resection of metastasis from rectal cancer after FOLFOX4+bevacizumab treatment].
    Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kure N; Kojima H
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1761-3. PubMed ID: 18931584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.